FUKUSHIMA Toshihiro

Researcher Profile & Settings

Research

Overview of research:
Clinical investigation, especially, chemotherapy for leukemia and myeloma. Mechanism of action of antitumor anthracyclines.

Education

• Fukui Medical School Graduate School Division of Medicine
• Fukui Medical School Faculty of Medicine

Degree

• Doctor(Medicine)

Research Activities

Published Papers

• Osteosarcoma Manifesting Systemic Inflammation and Histological Features Mimicking Plasma Cell-type Castleman Disease, Shino Fujimoto, Tomoyuki Sakai, Hiroshi Kawabata, Nozomu Kurose, Sohsuke Yamada, Mariko Doai, Munetaka Matoba, Haruka Iwao-Kawanami, Takafumi Kawanami, Shuichi Mizuta, Toshihiro Fukushima, Hiroki Mizumaki, Masaki Yamaguchi, Yasufumi Masaki, Internal Medicine, 58:2555-2560, Sep. 2019
• Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease?, Shino Fujimoto, Tomoyuki Sakai, Hiroshi Kawabata, Nozomu Kurose, Sohsuke Yamada, Kazue Takai, Sadao Aoki, Junya Kuroda, Makoto Ide, Keigo Setoguchi, Norifumi Tsukamoto, Haruka Iwao-Kawanami, Takafumi Kawanami, Shuichi Mizuta, Toshihiro Fukushima, Yasufumi Masaki, American Journal of Hematology, 94:975-983, Sep. 2019
• Final 3-year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second-line Treatment, (Masaya.Okada), Jun.Imagawa, Hideo.Tanaka, Hirohisa.Nakamae, Masayuki.Hino, Kazunori.Murai, Yoji.Ishida, Takashi.Kumagai, Seiichi.Sato, Kazuteru.Ohashi, Hisashi.Sakamaki, Hisashi.Wakita, Nobuhiko.Uoshima, Yasunori.Nakagawa, Yosuke.Minami, Masahiro.Ogasawara, Tomoharu.Takeoka, Hiroshi.Akasaka, Takahiko.Utsumi, Naokuni.Uike, Tsutomu.Sato, Sachiko.Ando, Kentuke.Usuki, Syuichi.Mizuta, Satoshi.Hashino, Testuhiko.Nomura, Masato.Shikami, Hisashi.Fukutani, Yokiko.Ohe, Hiroshi.Kosugi, Hiroshiko.Shibayama, Yasuhiro.Maeda, Toshihiro.Fukushima, Hirohito.Yamazaki, Kasuo.Tsubaki, Toshimasa.Kukita, Yoko.Adachi, Toshiki.Nataduka, Hiroto.Sakoda, Hisayuki.Yokoyama, Takahiro.Okamoto, Yukari.Shirasugi, Yasushi.Onishi, Clinical Lymphoma, Myeloma & Leukemia, 18:353-360, May 2018
• The treatment strategy of IgG4-related disease - from the result of prospective clinical study -, Yasufumi.Masaki, Shino.Fujimoto, Haruka.Kawanami (Iwao), Tomoyuki.Sakai, Takafumi.Kawanami, Yopshimasa.Fujita, Hiroshi.Kawabata, Toshihiro.Fukushima, 29:140-146, Jun. 2017
• A multicenter phase II prospective clinical trial of glucocorticoid for patients with untreated IgG4-related disease, Yasufumi.Masaki, shoko.Matsui, Takako.Saeki, Hiroto.Tsuboi, Shintaro.Hirata, Yasumori.Izumi, Taiichiro.Miyashita, Keita.Fujikawa, Hiroaki.Dobashi, Kentaro.Susaki, Hisanori.Morimoto, Kasutaka.Takagi, Mitsuhiro.Kawano,Tomoki.Origuchi, Yoko.Wada, Naoki.Takahashi, Masanobu.Horikashi, Hiroshi.Ogishima, Yasunori.Suzuki, Takafumi.Kawanami, Haruka.Kawanami Iwao, Tomoyuki.Sakai, Yoshimasa.Fujita, Toshihiro.Fukushima, Masatoshi.Saito, Ritsuro.Suzuki, Yuko.Morikawa, Tadashi.Yoshino, Shigeo.Nakamura, Masaru.Kojima, Nozomu.Kurose, Yasuharu.Sato, Yoshiya.Tanaka, Susumu.Sugai, Takayuki.Sumida, Modern Rheumatology, 27:849-854, May 2017
• How to diagnose and treat IgG4-related disease, Y.Masaki, S.Fujimoto, H.Kawanami(Iwao), T.Sakai, T.Kawanami, Y.Fujita, H.Kawabata, T.Fukushima, Journal of Kanazawa Medical University, 41:67-72, Dec. 2016
• Isolation of vascular smooth muscle antigen-reactive CD4(+)αβTh1 clones that induce pulmonary vasculitis in MRL/Mp-Fas(+/+) mice., Y.Fujita, T.Fujii, H.Shimizu, T.Sato, T.Nakamura, H.Iwao, A.Nakajima, M.Miki, T.Sakai, T.Kawanami, M.Tanaka, Y.Masaki, T.Fukushima, T.Okazaki, H.Umehara, T.Mimori, Cellular immunology, 303:50-54, 2016
  DOI:10.1016/j.cellimm.2016.03.004
• Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version., Y.Masaki, H.Kawabata, K.Takai, M.Kojima, N.Tsukamoto, Y.Ishigaki , N.Kurose, M.Ide, J.Murakami, K.Nara, H.Yamamoto, Y.Ozawa, H.Takahashi, K.Miura, T.Miyauchi, S.Yoshida, A.Momoi, N.Awano, S.Ikushima, Y.Ohta, N.Furuta, S.Fujimoto, H.Kawanami, T.Sakai, T.Kawanami, Y.Fujita, T.Fukushima, S.Nakamura, T.Kinoshita, S.Aoki, International journal of hematology, 103:686-692, 2016
  DOI:10.1007/s12185-016-1979-1
• Diagnosis and treatment of IgG4-related disease-Including IgG4-related skin disease-, Y.Masaki, H.Shimizu, T.Nakamura(Satoh), T.Nakamura, A.Nakajima, H.Kawanami(Iwao), T.Kawanami, K.Yamada, Y.Hamaguchi, M.Kawano, Y.Fujita, T.Fukushima, Journal of Environmental Dermatology and Cutaneous Allergology, 9:212-217, Oct. 2015
• Decreased expression of innate immunity-related genes in peripheral blood mononuclear cells from patients with IgG4-related disease, A.Nakajima, Y.Masaki, T.Nakamura, T.Kanawami, Y.Ishigaki, T.Takegami, M.Kawano, K.Yamada, N.Tsukamoto, S.Matsui, T.Saeki, K.Okazaki, T.Kamisawa, T.Miyashita, Y.Yakushijin, K.Fujikawa, M.Yamamoto, H.Hamano, T.Origuchi, S.Hirata, H.Tsuboi, T.Sumida, H.Morimoto, T.Sato, H.Iwao, M.Miki, T.Sakai, Y.Fujita, M.Tanaka, T.Fukushima, T.Okazaki, H.Umehara, PLoS One, 10:e0126582-e0126582, May 2015
  DOI:10.1371/journal.pone.0126582
• CD14+ follicular dendritic cells in lymphoid follicles may play a role in the pathogenesis of IgG4-related disease, T.Satoh-Nakamura, N.Kurose, T.Kawanami, T.Nakamura, H.Iwao-Kawanami, A.Nakajima, M.Miki, T.Sakai, Y.Fujita, M.Tanaka, T.Fukushima, Y.Masaki, Biomedical Research, 36:143-153, Feb. 2015
• t(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugs, (T.Narita), A.Inagaki, T.Kobayashi, Y.Kuroda, T.Fukushima, M.Nezu, S.Fuchida, H.Sakai, N.Sekiguchi, I.Sugiura, Y.Maeda, H.Takamatsu, N.Tsukamoto, D.Maruyama, Y.Kubota, M.Kojima, K.Sunami, T.Ono, M.Ri, K.Tobinai, S.Iida, Blood Cancer Journal, 5:e285-e285, 2015
• Prospective clinical study of R-CMD therapy for indolent B cell lymphoma and mantle cell lymphoma from the Hokuriku Hematology Oncology Study Group, T.Sakai, Y.Masaki, N.Otsuki, I.Sakamaki, S.Kishi, T.Miyazono, Y.Urasaki, J.Murakami, T.Satoh, T.Nakamura, H.Iwao, A.Nakajima, T.Kawanami, M.Miki, Y.Fujita, M.Tanaka, T.Fukushima, T.Okazaki, T.Ueda, Medical Oncology, 32:232-238, 2015
• Cefozopran, meropenem, or imipenem-cilastatin compared with cefepime as empirical therapy in febrile neutropenic adult patients: A multicenter prospective randomized trial, (T.Nakane), K.Tamura, M.Hino, T.Tamaki, I.Yoshida, T.Fukushima, Y.Tatsumi, Y.Nakagawa, K.Hatanaka, T.Takahashi, N.Akiyama, M.Tanimoto, K.Ohyashiki, A.Urabe, T.Masaoka, A.Kanamaru, Japan Febrile Neutropenia Study, Journal of Infection and Chemotherapy, 21:16-22, 2015
  DOI:10.1016/j.jiac.2014.08.026
• IgG4-related disease:Diagnostic methods and therapeutic strategies in Japan, Y.Masaki, H.Shimizu, T.Sato, T.Nakamura, A.Nakajima, H.Iwao, M.Miki, T.Sakai, T.Kawanami, Y.Fujita, M.Tanaka, T.Fukushima, Journal of clinical and experimental hematopathology : JCEH., 54:95-101, 2014
• Deficient leptin signaling ameliorates systemic lupus erythematosus lesions in MRL/Mp-Faslpr mice, Y.Fujita, T.Fujii, T.Mimori, T.Sato, T.Nakamura, H.Iwao, A.Nakajima, M.Miki, T.Sakai, T.Kawanami, M.Tanaka, Y.Masaki, T.Fukushima, T.Okazaki, H.Umehara, Journal of immunology (Baltimore, Md. : 1950), 192:979-984, 2014
• Chromosomal Translocation (14;16)-Positive Multiple Myeloma Shows Negativity for CD56 Expression and Unfavorable Outcome Even in the Era of Novel Drugs, Narita, Tomoko;Inagaki, Atsushi;Kobayashi, Tsutomu;Kuroda, Yoshiaki;Fukushima, Toshihiro;Nezu, Masahiko;Fuchida, Shin-ichi;Sakai, Hirotaka;Sekiguchi, Naohiro;Sugiura, Isamu;Maeda, Yoshinobu;Takamatsu, Hiroyuki;Tsukamoto, Norifumi;Maruyama, Dai;Kubota, Yasushi;Kojima, Minoru;Sunami, Kazutaka;Ono, Takaaki;Ri, Masaki;Tobinai, Kensei;Iida, Shinsuke, BLOOD, 124, 2014
• Deficient leptin signaling ameliorates systemic lupus erythematosus lesions in MRL/Mp-Faslpr mice, Y.Fujita, T.Fujii, T.Mimori, T.Sato, T.Nakamura, H.Iwao, A.Nakajima, M.Miki, T.Sakai, T.Kawanami, M.Tanaka, Y.Masaki, T.Fukushima, T.Okazaki, H.Umehara, Journal of immunology (Baltimore, Md. : 1950), 192:979-984, 2014
• Japanese variant of multicentirc cattleman's disease associated with serositis and thrombocytopenia-a report of two cases: Is TAFRO syndrome(Castleman-Kojima Disease) a distinct clinicopathological entity?, Y.Masaki, A.Nakajima, H.Iwao, N.Kurose, T.Sato, T.Nakamura, M.Miki, T.Sakai, T.Kawanami, T.Sawaki, Y.Fujita, M.Tanaka, T.Fukushima, T.Okazaki, H.Umehara, Journal of clinical and experimental hematopathology : JCEH., 53:79-85, Jun. 2013
• A patient with persistent renal AL amyloid deposition after clinical remission by HDM/SCT therapy., H.Okuyama, H.Yamaya, T.Fukushima, H.Yokoyama, Clinical nephrology., 79:233-236, Mar. 2013
• Efficacy and safety of bortezomib plus dexamethasone therapy for refractory or relapsed multiple myeloma: once-weekly administration of bortezomib may reduce the incidence of gastrointestinal adverse events, T.Fukushima, T.Nakamura, H.Iwao, A.Nakajima, M.Miki, T.Sato, T.Sakai, T.Sawaki, Y.Fujita, M.Tanaka, Y.Masaki, H.Nakajima, Y.Motoo, H.Umehara, Anticancer research., 31:2297-2302, Sep. 2011
• Intravascular large B-cell lymphoma: an important cause of fever of unknown origin, Y.Masaki, M.Miki, T.Sakai, T.Sawaki, T.Fukushima, H.Umehara, 63:435-441, May 2011
• Iron chelation therapy with deferasirox induced complete remission in a patient with chemotherapy-resistant acute monocytic leukemia, T.Fukushima, H.Kawabata, T.Nakamura, H.Iwao, A.Nakajima, M.Miki, T.Sakai, T.Sawaki, Y.Fujita, M.Tanaka, Y.Masaki, Y.Hirose, H.Umehara, Anticancer research., 31:1741-1744, May 2011
• Rapid response of plasmacytomas to lenalidomide plus low-dose dexamethasone therapy in a patient with relapsed multiple myeloma, T.Fukushima, T.Nakamura, H.Iwao, H.Umehara, American journal of hematology., 86:893, 2011
• High-dose methotrexate with R-CHOP therapy for the treatment of patients with primary central nervous system lymphoma, Y.Masaki, M.Miki, Y.Sun, T.Nakamura, H.Iwao, A.Nakajima, N.Kurose, T.Sakai, Z.Jin, T.Sawaki, T.Kawanami, Y.Fujita, M.Tanaka, T.Fukushima, Y.Hirose, H.Umehara, International journal of hematology., 93:720-726, 2011
• Primary neurolymphomatosis of the cervical nerve root, M.miki, Y.Masaki, T.Nakamura, H.Iwao, A.Nakajima, T.Sakai, T.Sawaki, T.Kawanami, M.Kaito, N.Kurose, Y.Fujita, M.Tanaka, T.Fukushima, Y.Hirose, H.Umehara, 51:564-567, Jul. 2010
• Complete response obtained by bortezomib plus dexamethasone in a patient with relapsed multiple myeloma with multiple plasmacytomas, T.Fukushima, T.Nakamura, M.Miki, T.Sakai, H.Iwao, A.Nakajima, T.Sawaki, Y.Fujita, M.Tanaka, Y.Masaki, Y.Hirose, H.Umehara, Anticancer research., 30:3791-3794, Jun. 2010
• DIP2 disco-interacting protein 2 homolog A (Drosophila) is a candidate receptor for follistatin-related protein/follistaitin-like 1 - analysis of their binding with TGF-β superfamily proteins, M.Tanaka, K.Murakami, S.Ozaki, Y.Imura, X.Tong, T.Watanabe, T.Sawaki, T.Kawanami, D.Kawabata, T.Fujii, T.Usui, Y.Masaki, T.Fukushima, Z.Jin, H.Umehara, T.Mimori, The FEBS journal, 277:4278-4289, 2010
• Very Good Partial Response and Long Time to Progression by Short-Term Bortezomib Plus Dexamethasone Therapy for a Patient with Relapsed and Refractory Multiple Myeloma―A Case Report, 36:1387-1389, Aug. 2009
• Intravascular large B cell lymphoma:proposed of the strategy for early diagnosis and treatment of patients with rapid deteriorating condition, Y.Masaki, L.Dong, A.Nakajima, H.Iwao, M.Miki, N.Kurose, E.Kinoshita, T.Nojima, T.Sawaki, T.Kawanami, M.Tanaka, K.Shimoyama, C.Kim, M.Fukutoku, H.Kawabata, T.Fukushima, Y.Hirose, T.Takiguchi, S.Konda, S.Sugai, H.Umehara, International journal of hematology., 89:600-610, Jun. 2009
• Proposal for a new clinical entity,IgG4-positive multiorgan lymphoproliferative syndrome:analysis of 64 cases of IgG4-related disorders, Y.Masaki, L.Dong, N.Kurose, K.Kitagawa, Y.Morikawa, M.Yamamoto, H.Takahashi, Y.Shinomura, K.Imai, T.Saeki, A.Azumi, S.Nakada, E.Sugiyama, S.Matsui, T.Origuchi, S.Nishiyama, I.Nishimori, T.Nojima, K.Yamada, M.Kawano, Y.Zen, M.Kaneko, K.Miyazaki, K.Tsubota, K.Eguchi, K.Tomoda, T.Sawaki, T.Kawanami, M.Tanaka, T.Fukushima, S.Sugai, H.Umehara, Annals of the rheumatic diseases., 68:1310-1315, 2009
• Successful treatment of amegakaryocytic thrombocytopenia with anti-CD20 antibody(rituximab)in a patient with systemic lupus erythematosus, T.Fukushima, L.Dong, T.Sakai, T.Sawaki, M.Miki, M.Tanaka, Y.Masaki, Y.Hirose, M.Kuwana, H.Umehara, Lupus, 17:210-214, Mar. 2008
• A case report of an adult with severe hyperlipidemia during acute lymphocytic leukemia induction therapy successfully treated with plasmapheresis, M.Nakagawa, S.Kimura, K.Fujimoto, H.Atsumi, J.Imura, Y.Chikazawa, H.Imamura, H.Okuyama, H.Yamaya, T.Fukushima, A.Nakagawa, M.Asaka, H.Yokoyama, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy., 12:509-513, Jan. 2008
• Impaired TCR signaling through dysfunction of lipidrafts in sphingomyelin synthase 1(SMS1)-knockdown T cells, Z.Jin, C.Huang, L.Dong, S.Goda, T.Kawanami, T.Sawaki, T.Sakai, X.Tong, Y.Masaki, T.Fukushima, M.Tanaka, T.Mimori, H.Tojo, E.Bloom, T.Okazaki, H.Umehara, International immunology., 20:1427-1437, 2008
• Analysis of clinical significance of anti-cyclic citrullinated peptide antibody (anti-CCP antibody) in rheumatoid arthritis(RA)., (K.Shimoyama), N.Ogawa, T.Sakai, T.Sawaki, T.Kawanami, H.Karasawa, Y.Masaki, M.Tanaka, T.Fukushima, Y.Hirose, H.Umehara, 30:408-413, Oct. 2007
• Cloning and expression of two human recombinant monoclonal Fab fragments specific for EBV viral capsid antigen, L.Dong, Y.Masaki, T.Takegami, T.Kawanami, K.Itoh, Z.Jin, C.Huang, X.Tong, T.Fukushima, M.Tanaka, T.Sawaki, T.Sakai, S.Sugai, T.Okazaki, Y.Hirose, H.Umehara, International immunology., 19:331-336, Mar. 2007
• Identification of human salivary stem cells from cultured labial minor salivary cells, T.Kawanami, Y.Matsuzaki, T.Sawaki, T.Sakai, Z.Jin, Y.Masaki, T.Fukushima, M.Tanaka, H.Umehara, 30:455-460, 2007
• Sjogren's Syndrome and Lymphoma Development, L.Dong, Y.Masaki, M.Tanaka, T.Fukushima, T.Okazaki, H.Umehara, Current immunology reviews, 3:289-296, 2007
• Clonality analysis of lymphoproliferative disorders in patients with Sjogren's syndrome, L.Dong, Y.Masaki, T.Takegami, Z.Jin, C.Huang, T.Fukushima, T.Sawaki, T.Kawanami, T.Saeki, K.Kitagawa, S.Sugai, T.Okazaki, Y.Hirose, H.Umehara, Clinical and experimental immunology., 150:279-284, 2007
• Urinary pseudouridine in patients with lymphoma:Comparison with other clinical parameters, Y.Masaki, K.Itoh, T.Sawaki, H.Karasawa, T.Kawanami, T.Fukushima, H.Kawabata, Y.Wano, Y.Hirose, T.Suzuki, S.Sugai, H.Umehara, Clinica chimica acta; international journal of clinical chemistry., 371:148-151, 2006
• Myelodysplastic syndrome complicated with inflammatory intestinal ulcers: significance of trisomy 8, (H.Kawabata), T.Sawaki, T.Kawanami, K.Shimoyama, H.Karasawa, T.Fukushima, Y.Masaki, N.Ogawa, Y.Hirose, K.Ozaki, K.Shimanaka, S.Takase, H.Ueno, H.Umehara, Internal medicine (Tokyo, Japan), 45:1309-1314, 2006
• Fractalkine in rheumatoid arthritis and allied conditions, H.Umehara, M.Tanaka, T.Sawaki, Z.X.Jin, C.R.Huang, L.Dong, T.Kawanami, H.Karasawa, Y.Masaki, T.Fukushima, Y.Hirose, T.Okazaki, Modern rheumatology / the Japan Rheumatism Association., 16:124-130, 2006
• Association of Epstein-Barr virus with human immunodeficiency virus-negative peripheral T-cell lymphomas in Japan, Y.Hirose, Y.Masaki, T.Sawaki, K.Shimoyama, H.Karasawa, H.Kawabata, T.Fukushima, N.Ogawa, Y.Wano, H.Umehara, European journal of haematology., 76:109-118, 2006
• A case of Mikulicz's disease complicated with interstitial nephritis successfully treated by high-dose corticosteroid, K.Shimoyama, N.Ogawa, T.Sawaki, H.Karasawa, Y.Masaki, H.Kawabata, T.Fukushima, Y.Wano, Y.Hirose, H.Umehara, Modern rheumatology / the Japan Rheumatism Association., 16:176-182, 2006
• Sjogren's syndrome, H.Umehara, T.Sawaki, T.Kawanami, Y.Masaki, T.Fukushima, 67:511-516, May 2005
• MLL gene rearrangement in acute myelogenous leukemia after exposure to tegafur/uracil, T Fukushima, N Yoshio, Y Noto, H Kida, Int J Hematol, 75: 178-181, 2002
• Low-dose dasatinib in older patients with chronic myeloid leukaemia in chronic phase (DAVLEC): a single-arm,multicentre, phase 2 trial, (Kazunori Murai), Hiroshi Ureshino, Takashi Kumagai, Hideo Tanaka, Kaichi Nishiwaki, Satoshi Wakita, Koiti Inokuchi, Toshihiro Fukushima, Chikashi Yoshida, Nobushiko Uoshima, Toru Kiguchi, Masayuki Mita, Jun Aoki, Satoshi Kimura, Kaori Karimata, Kensuke Usuki, Joji Shimono, Yoshiaki Chinen, Junya Kuroda, Yasufumi Matsuda, Kensuke Nakao,Takaaki Ono, Katsumichi Fujimaki, Hirohiko Shibayama, Chisaki Mizumoto, Tomoharu Takeoka, Katsuhiro Io, Takeshi Kondo, Masatomo Miura, Yousuke Minami, Takayuki Ikezone, Jun Imagawa, Ayako Takamori, Atsushi Kawaguchi, Junichi Sakamoto, Shinya Kimura, Lancet Haematology, 8:e902-e911, Dec. 2021
• Comprehensive analysis of protein-expression changes specific to immunoglobulin G4-related disease, Takafumi Kawanami, Haruka Kawanami-Iwao, Takanobu Takata, Yasuhito Ishigaki, Naohisa Tomosugi, Tsutomu Takegami, Hiroto Yanagisawa, Shino Fujimoto, Tomoyuki Sakai, Yoshimasa Fujita, Kazunori Yamada, Shuichi Mizuta, Hiroshi Kawabata, Toshihiro Fukushima, Yuko Hirose, Yasufumi Masaki, Clinica Chimica Acta, 523:45-57, 2021
• Faggot cells in acute myeloid leukemia with t(7;11)(p15;p15) and NUP98-HOXA9 fusion, Hiroto Yanagisawa, Shuichi Mizuta, Hiroshi Kawabata, Shino Fujimoto, Tomoyuki Sakai, Haruka Iwao-Kawanami, Takafumi Kawanami, Kazunori Yamada, Toshihiro Fukushima, Katsunori Kyoda, Yasufumi Masaki, Annals of Hematology, 100:2121-2123, Aug. 2021
• Prognostic impacts of serum levels of C-reactive protein, albumin, and total cholesterol in patients with myelodysplastic syndromes, Hiroto Yanagisawa, Hiroshi Kawabata, Yusuke Ueda, Kotaro Arita, Haruka Iwao-Kawanami, Tomoyuki Sakai, Takafumi Kawanami, Kazunori Yamada, Shuichi Mizuta, Toshihiro Fukushima, Yasufumi Masaki, International Journal of Hematology, 116:81-88, 2022
• TAFRO syndrome: A disease requiring immediate medical attention, Yasufumi Masaki, Yusuke Ueda, Hiroto Yanagisawa, Kotaro Arita, Tomoyuki Sakai, Kazunori Yamada, Shuichi Mizuta, Toshihiro Fukushima, Kazue Takai, Sadao Aoki, and Hiroshi Kawabawa, Internal Medicien, 62:27-32, Jan. 2023
• Prospective therapeutic studies of disseminated extranodal large B-cell lymphoma including intravascular large B-cell lymphoma, Tomoyuki Sakai, Yusuke Ueda, Hiroto Yanagisawa, Kotaro Arita, Haruka Iwao, Kazunori Yamada, Shuichi Mizuta, Hiroshi Kawabata, Toshihiro Fukushima, Katsunori Tai, Shinji Kishi, Koji Morinaga, Jun Murakami, Hiroyuki Takamatsu, Yasushi Terasaki, Nobuyuki Yoshio, Yukio Kondo, Hirokazu Okumura, Sadaya Matano, Masaki Yamaguchi, Hiroshi Tsutani, Yasufumi Masaki, Global Health & Medicine, 6:277-281, Aug. 2024
• Fatal hemophagocytic lymphohistiocytosis with intravascular large B-cell lymphoma following coronavirus disease 2019 vaccination in a patient with systemic lupus erythematosus: an intertwined case, Yusuke Ueda, Tomoyuki Sakai, Kazunori Yamada, Kotaro Arita, Yoko Ishige, Daisuke Hoshi, Hiroto Yanagisawa, Haruka Iwao-Kawanami, Takafumi Kawanami, Shuichi Mizuta, Toshihiro Fukushima, Sohsuke Yamada, Akihiro Yachie, Yasufumi Masaki, Immunological Medicine, 47:192-199, Sep. 2024
  DOI:DOI: 10.1080/25785826.2024.2338594
• IgG4-related disease concomitant with diffuse large B-cell lymphoma, Hiroto Yanagisawa, Keita Mishima, Yaya Yamanouchi, Yusuke Ueda, Takahiro Yamano, Haruka Iwao-Kawanami, Tomoyuki Sakai, Takafumi Kawanami, Kazunori Yamada, Mitsuhiro Kawano, Shuichi Mizuta, Toshihiro Fukushima, Yasufumi Masaki, 64:953-957, 2025